Taiwan Biomaterial Co., Ltd. (TPEX:6649)
27.90
-3.10 (-10.00%)
Nov 20, 2026, 1:30 PM CST
Taiwan Biomaterial Revenue
Taiwan Biomaterial had revenue of 43.83M TWD in the quarter ending September 30, 2026, a decrease of -39.78%. This brings the company's total for the last twelve months to 153.37M, down -24.55% year-over-year. In the year 2025, Taiwan Biomaterial had annual revenue of 220.40M with 128.22% growth. That makes Taiwan Biomaterial the 40,266th largest company in the world by revenue and 2,072nd in Taiwan.
Revenue (ttm)
153.37M
Revenue Growth
-24.55%
P/S Ratio
7.64
Revenue / Employee
n/a
Employees
46
Market Cap
1.17B
Revenue by Geography
- United States 217.85M 98.8%
- Taiwan 2.55M 1.2%
Fiscal year ended Dec 31, 2025 See the full Taiwan Biomaterial breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 220.40M | 123.83M | 128.22% |
| Dec 31, 2024 | 96.57M | 23.74M | 32.59% |
| Dec 31, 2023 | 72.84M | -54.47M | -42.79% |
| Dec 31, 2022 | 127.31M | 85.63M | 205.48% |
| Dec 31, 2021 | 41.67M | 23.60M | 130.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.82B |
| OK Biotech | 1.72B |
| Dynamic Medical Technologies | 1.42B |
| AViTA | 1.05B |
| Bioptik Technology Incorporation | 891.73M |
| Medimaging Integrated Solution | 744.42M |
| Radiant Innovation | 417.97M |
| Wiltrom | 314.12M |